121 related articles for article (PubMed ID: 38819442)
1. The Burden of iPLEDGE Requirements on Dermatologists: A Survey Study.
Owens KE; Jiang SW; Liu WW; Nicholas MW
Arch Dermatol Res; 2024 May; 316(6):305. PubMed ID: 38819442
[No Abstract] [Full Text] [Related]
2. Contraceptive counseling for iPLEDGE and its burden on dermatologists.
Owens KE; Jiang SW; Nicholas MW
Arch Dermatol Res; 2024 May; 316(6):287. PubMed ID: 38805059
[TBL] [Abstract][Full Text] [Related]
3. Administrative Burden of iPLEDGE Deters Isotretinoin Prescriptions: Results From a Survey of Dermatologists.
Lee G; Wolf JR; Somers KE
Cutis; 2022 Jul; 110(1):44-47. PubMed ID: 36179224
[TBL] [Abstract][Full Text] [Related]
4. Emergency contraception in the iPLEDGE program: A cross-sectional survey of pediatric dermatology provider understanding and practice.
Smiley CE; Butt M; Zaenglein AL
Pediatr Dermatol; 2022 Sep; 39(5):727-730. PubMed ID: 35918308
[TBL] [Abstract][Full Text] [Related]
5. Dermatologists' Perspectives on Defining Moderate Psoriasis: The Canadian Moderate Psoriasis Survey.
Gooderham M; Papp K; Albrecht L; Grewal P; Gaudreau AJ
J Drugs Dermatol; 2021 Feb; 20(2):126-132. PubMed ID: 33538558
[TBL] [Abstract][Full Text] [Related]
6. Understanding linguistic diversity in the dermatology workforce and requirements to provide medical care in a non-english language: a survey.
Torres AN; Costanza MB; Batra P; Castanedo-Tardan MP
Arch Dermatol Res; 2024 May; 316(5):160. PubMed ID: 38734784
[No Abstract] [Full Text] [Related]
7. Psychodermatology: knowledge, awareness, and attitude of dermatologists in Kazakhstan.
Markabayeva A; Ospanova S; Jafferany M
Int J Dermatol; 2020 Apr; 59(4):e105-e109. PubMed ID: 31364766
[No Abstract] [Full Text] [Related]
8. Isotretinoin and mental health: a survey of Scottish Dermatology Society members.
Affleck AG; Stewart AM; Nicolson J; Salmon N
Clin Exp Dermatol; 2020 Jun; 45(4):476-478. PubMed ID: 31730241
[No Abstract] [Full Text] [Related]
9. Evaluation of compliance with isotretinoin PPP recommendations and exploration of reasons for non-compliance: Survey among French-speaking health care professionals and patients in Belgium.
Lelubre M; Hamdani J; Senterre C; Amighi K; Peres M; Schneider MP; Bugnon O; De Vriese C
Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):668-673. PubMed ID: 29726056
[TBL] [Abstract][Full Text] [Related]
10. Patient and physician perspectives on teledermatology at an academic dermatology department amid the COVID-19 pandemic.
Asabor EN; Bunick CG; Cohen JM; Perkins SH
J Am Acad Dermatol; 2021 Jan; 84(1):158-161. PubMed ID: 32946971
[No Abstract] [Full Text] [Related]
11. iPLEDGE Must Abstain from Abstinence.
Lowery K; Rosen T; Malek J
J Clin Aesthet Dermatol; 2020 Jun; 13(6):54-56. PubMed ID: 32884622
[TBL] [Abstract][Full Text] [Related]
12. Insight into the management of actinic keratosis: a qualitative interview study among general practitioners and dermatologists.
Noels EC; Lugtenberg M; van Egmond S; Droger SM; Buis PAJ; Nijsten T; Wakkee M
Br J Dermatol; 2019 Jul; 181(1):96-104. PubMed ID: 30801664
[TBL] [Abstract][Full Text] [Related]
13. Study Expresses Concerns About the Safety of Medical Spas.
Van Wicklin SA
Plast Surg Nurs; 2020; 40(2):63-65. PubMed ID: 32459750
[No Abstract] [Full Text] [Related]
14. The views of consultant dermatologists on creating centralized skin lesion units.
Scrivens LJ; Goulding JMR; Allen KJ
Br J Dermatol; 2019 Jun; 180(6):1525-1526. PubMed ID: 30431145
[No Abstract] [Full Text] [Related]
15. Patterns of prescribing isotretinoin: focus on women of childbearing potential.
Doering PL; Araujo OE; Frohnapple DJ; LaMarre AS; Flowers FP
Ann Pharmacother; 1992 Feb; 26(2):155-61. PubMed ID: 1554922
[TBL] [Abstract][Full Text] [Related]
16. Smartphone app review: British National Formulary (BNF).
Salam A; Ashack KA; Walsh S
Br J Dermatol; 2018 Dec; 179(6):1424-1432. PubMed ID: 30393981
[No Abstract] [Full Text] [Related]
17. Educational video improves dermatology residents' understanding of Mohs micrographic surgery: A survey-based matched cohort study.
McNeil E; Reich H; Hurliman E
J Am Acad Dermatol; 2020 Sep; 83(3):926-927. PubMed ID: 31935427
[No Abstract] [Full Text] [Related]
18. The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system.
Shin J; Cheetham TC; Wong L; Niu F; Kass E; Yoshinaga MA; Sorel M; McCombs JS; Sidney S
J Am Acad Dermatol; 2011 Dec; 65(6):1117-25. PubMed ID: 21565419
[TBL] [Abstract][Full Text] [Related]
19. Women's experiences with isotretinoin risk reduction counseling.
Werner CA; Papic MJ; Ferris LK; Lee JK; Borrero S; Prevost N; Schwarz EB
JAMA Dermatol; 2014 Apr; 150(4):366-71. PubMed ID: 24258663
[TBL] [Abstract][Full Text] [Related]
20. Concomitant use of isotretinoin and contraceptives before and after iPledge in the United States.
Pinheiro SP; Kang EM; Kim CY; Governale LA; Zhou EH; Hammad TA
Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1251-7. PubMed ID: 23913625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
